Free Trial
NASDAQ:SCNI

Scinai Immunotherapeutics (SCNI) Stock Price, News & Analysis

Scinai Immunotherapeutics logo
$2.20 -0.07 (-3.08%)
Closing price 07/3/2025 03:03 PM Eastern
Extended Trading
$2.24 +0.04 (+1.82%)
As of 07/3/2025 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Scinai Immunotherapeutics Stock (NASDAQ:SCNI)

Key Stats

Today's Range
$2.17
$2.36
50-Day Range
$2.20
$3.25
52-Week Range
$1.90
$8.92
Volume
73,299 shs
Average Volume
235,370 shs
Market Capitalization
$2.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SCNI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

SCNI Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
See More Headlines

SCNI Stock Analysis - Frequently Asked Questions

Scinai Immunotherapeutics' stock was trading at $3.35 at the beginning of 2025. Since then, SCNI shares have decreased by 34.3% and is now trading at $2.20.

Scinai Immunotherapeutics Ltd. Sponsored ADR (NASDAQ:SCNI) posted its quarterly earnings data on Wednesday, May, 7th. The company reported ($10.40) earnings per share for the quarter. The business had revenue of $0.21 million for the quarter.

Scinai Immunotherapeutics's stock reverse split before market open on Tuesday, May 21st 2024.The 1-10 reverse split was announced on Tuesday, May 21st 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SCNI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scinai Immunotherapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), AppLovin (APP), e.l.f. Beauty (ELF) and Disc Medicine (IRON).

Company Calendar

Last Earnings
5/07/2025
Today
7/05/2025
Next Earnings (Estimated)
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCNI
Previous Symbol
NASDAQ:SCNI
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$4.80 million
Pretax Margin
728.88%

Debt

Sales & Book Value

Annual Sales
$660 thousand
Price / Cash Flow
N/A
Book Value
$5.10 per share
Price / Book
0.43

Miscellaneous

Free Float
391,000
Market Cap
$2.20 million
Optionable
Not Optionable
Beta
2.04
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:SCNI) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners